· Volume surge · DXCM

DexCom Inc (DXCM) lifts 16.6% as weekly chart turns higher

The medical-device stock’s medium-term advance is being supported by active trend readings and heavier turnover.

DexCom glucose monitoring devices beside a financial market data screen.

DexCom Inc (DXCM) closed the latest week at $83.45, rising 16.6% in the weekly price path over 52 weeks. The continuous glucose monitoring maker has also gained 17.1% over four weeks and 37.7% over twelve weeks.

Confirmation improved with the trend signal active, Market Dynamics positive at 0.84, and Relative Strength at 10.5. Volume was also firm, with 33.0 million shares traded against a 13-week average of 27.2 million, while the active-mover screen flagged turnover at about 1.9x normal.